Land: Australien
Sprog: engelsk
Kilde: APVMA (Australian Pesticides and Veterinary Medicines Authority)
XYLAZINE AS THE HYDROCHLORIDE
AVET HEALTH LIMITED
PARENTERAL LIQUID/SOLUTION/SUSPENSION
XYLAZINE AS THE HYDROCHLORIDE THIAZOLE Active 20.0 mg/ml
20 mL; 50 mL
VM - Veterinary Medicine
CENTRAL NERVOUS SYSTEM
Poison schedule: 4; Withholding period: MEAT: DO NOT USE less than 28 days befor e slaughter for human consumption. MI LK: 0 days EXPORT SLAUGHTER INTERVAL (E SI): An ESI has not been established for this product. Note – observing the mea t withholding period may not be sufficie nt to mitigate potential risks to export trade. Trade advice should be sought fr om Avet Health Pty Ltd on 1300 28 38 28 before using this product.; Host/pest details: CAT: [ANALGESIC, MUSCLE RELAXANT]; CATTLE: [ANALGESIC, MUSCLE RELAXANT]; DOG: [ANALGESIC, MUSCLE RELAXANT]; GOAT: [ANALGESIC, MUSCLE RELAXANT]; SHEEP: [ANALGESIC, MUSCLE RELAXANT]
Registered
2023-07-01
AVET Xylazine 20 mg/mL Analgesic, Sedative and Muscle Relaxant Injection 92887 / 137069 Product Name: APVMA Approval No: Label Name: AVET Xylazine 20 mg/mL Analgesic, Sedative and Muscle Relaxant Injection Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Constituent Statements: 20 mg/mL XYLAZINE (as hydrochloride) Claims: An analgesic, sedative and muscle relaxant injection for use in dogs, cats, sheep, goats and cattle. Net Contents: 20 mL 50 mL Directions for Use: Restraints: Contraindications: This product is contraindicated for use in animals in the last month of pregnancy as it may precipitate an early parturition or abortion. This product is contraindicated for intra-arterial administration. This product is contraindicated in dogs or cats in conditions where emesis is undesirable e.g. gastric dilation and torsion, ingestion of caustic liquid or sharp foreign objects. Precautions: Side Effects: Salivation, hyperthermia, transient diarrhoea and ruminal atony may be observed. Atropine premedication may help prevent excessive salivation in ruminants. It is not recommended that sedated animals be left in an environment where overheating could occur due to inability to adequately thermoregulate. In cattle, temperature elevation is RLP APPROVED highest 4-5 hours after an intramuscular injection, and slowly returns to pre-injection levels around 14 hours later. Normal precautions in relation to prolonged recumbency should be observed in ruminants to avoid bloating, ruminal atony, regurgitation and aspiration pneumonia. Dogs and Cats: It is normal for AVET Xylazine 20 to cause cardiopulmonary depression manifested by a decrease in heart rate, stroke volume, cardiac output and respiratory rate together with an increase in total peripheral resistance. These effects are transitory and of no clinical significance in healthy animals, however, it is not recommended to use AVET Xylazine 20 where there is cardiovascular disease including conditions of shock, or respiratory Læs hele dokumentet